Press Coverage

See Beyond the Surface: How Cellvizio® Redefines Accuracy for Detecting and Treating Cancers

13 August 2025

This comprehensive feature written by Daryl C. Donatelli, MBA, President, U.S. & Head of Global Marketing, Mauna Kea Technologies explores the Cellvizio platform and details how the technology is transforming cancer detection and treatment across gastroenterology and pulmonology, offering physicians unprecedented accuracy in diagnosing pancreatic cysts, Barrett’s esophagus, and lung lesions. The article highlights how real-time cellular visualization enables earlier detection, reduces the need for repeat procedures, and helps physicians make more confident treatment decisions, ultimately leading to improved patient outcomes and reduced healthcare costs.

Read the full article here

Latest News

Mauna Kea Technologies Announces 2025 Half-Year Results 

Mauna Kea Technologies Announces 2025 Half-Year Results 

Mauna Kea Technologies Presents the Final Terms of its Safeguard Plan

Mauna Kea Technologies Presents the Final Terms of its Safeguard Plan

Mauna Kea Technologies and Endotherapeutics Announce Cellvizio® First Australian Orders, Advancing CellTolerance® Commercial Expansion 

Mauna Kea Technologies and Endotherapeutics Announce Cellvizio® First Australian Orders, Advancing CellTolerance® Commercial Expansion 

No results found.